News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
632,890 Results
Type
Article (61104)
Company Profile (78)
Press Release (571708)
Section
Business (174218)
Career Advice (2712)
Deals (32478)
Drug Delivery (86)
Drug Development (76871)
Employer Resources (148)
FDA (14883)
Job Trends (13875)
News (305634)
Policy (29104)
Tag
Academia (2870)
Alliances (42980)
Alzheimer's disease (1158)
Approvals (14813)
Artificial intelligence (116)
Bankruptcy (283)
Best Places to Work (10701)
Breast cancer (102)
Cancer (873)
Career advice (2295)
Cell therapy (200)
Clinical research (60674)
Collaboration (307)
Compensation (95)
COVID-19 (2509)
C-suite (79)
Cystic fibrosis (77)
Data (830)
Diabetes (120)
Diagnostics (5895)
Drug pricing (79)
Earnings (58348)
Employer resources (131)
Events (91649)
Executive appointments (248)
FDA (15311)
Funding (277)
Gene therapy (145)
GLP-1 (534)
Government (4394)
Healthcare (18129)
Infectious disease (2575)
Inflammatory bowel disease (100)
Interviews (521)
IPO (14597)
Job creations (3437)
Job search strategy (1940)
Layoffs (435)
Legal (6497)
Lung cancer (144)
Manufacturing (137)
Medical device (12457)
Medtech (12462)
Mergers & acquisitions (17937)
Metabolic disorders (323)
Neuroscience (1384)
NextGen Class of 2024 (6376)
Non-profit (4318)
Northern California (1063)
Obesity (185)
Opinion (201)
Patents (93)
People (58416)
Phase I (19002)
Phase II (26779)
Phase III (19572)
Pipeline (198)
Postmarket research (2480)
Preclinical (8099)
Radiopharmaceuticals (238)
Rare diseases (178)
Real estate (5986)
Regulatory (19377)
Research institute (2392)
Resumes & cover letters (404)
Southern California (966)
Startups (3334)
United States (10295)
Vaccines (520)
Weight loss (138)
Date
Today (77)
Last 7 days (678)
Last 30 days (2562)
Last 365 days (32575)
2024 (27547)
2023 (36442)
2022 (46740)
2021 (51700)
2020 (50841)
2019 (44932)
2018 (34178)
2017 (30804)
2016 (30173)
2015 (35584)
2014 (28545)
2013 (25097)
2012 (26381)
2011 (26623)
2010 (25106)
Location
Africa (870)
Arizona (133)
Asia (37326)
Australia (6709)
California (2351)
Canada (1090)
China (189)
Colorado (111)
Connecticut (110)
Europe (87016)
Florida (357)
Georgia (95)
Illinois (315)
Indiana (155)
Kansas (87)
Maryland (469)
Massachusetts (1800)
Michigan (142)
Minnesota (205)
New Jersey (758)
New York (738)
North Carolina (664)
Northern California (1063)
Ohio (116)
Pennsylvania (648)
South America (1174)
Southern California (966)
Texas (344)
Utah (77)
Washington State (285)
632,890 Results for "university of british columbia".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
PreveCeutical Commences Litigation Against Former Legal Counsel in the British Columbia Supreme Court Alleging Professional Negligence
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), announces that it, along with certain others, filed a Notice of Civil Claim (the “Claim”) in the British Columbia Supreme Court on June 5, 2024 against its former legal counsel (the “Defendants”).
June 6, 2024
·
5 min read
Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order
Cell MedX Corp. (“Cell MedX” or the “Company”) (OTC Pink: CMXC) announces that on November 22, 2023, the British Columbia Securities Commission
November 28, 2023
·
4 min read
Press Releases
Aspect Biosystems Announces $200 Million Partnership with the Governments of Canada and British Columbia to Advance Development of Bioprinted Tissue Therapeutics
July 23, 2024
·
3 min read
Andira Advances Lead Cannabinoid Compositions for Metastatic Breast Cancer through a Collaborative Research Agreement with Canada Research Chair in Oncology Dr. Karla Williams at the University of British Columbia
Andira Pharmaceuticals announces it will carry out pharmacologic characterization of its lead compounds for metastatic breast cancer through a collaborative research program with the University of British Columbia (UBC), Vancouver.
March 22, 2023
·
3 min read
Mitsubishi Tanabe Pharma Canada Announces That Company’s Oral Treatment Formulation for Amyotrophic Lateral Sclerosis (ALS) Has Been Added to the Provincial Drug Plan in British Columbia
Mitsubishi Tanabe Pharma Canada, a subsidiary of Mitsubishi Tanabe Pharma America, Inc., announced that RADICAVA® Oral Suspension is now covered under British Columbia PharmaCare for the treatment of people living with amyotrophic lateral sclerosis, a rapidly progressive, neurodegenerative disease.
August 18, 2023
·
4 min read
AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients
AbCellera (Nasdaq: ABCL) today announced a CA$701 million co-investment with the Governments of Canada and British Columbia to build new capabilities and infrastructure to develop innovative antibody-based medicines and strengthen Canada’s leadership in clinical research, manufacturing, and drug development.
May 24, 2023
·
8 min read
Solarvest Announces Annual General Meeting of Shareholders
Vancouver, British Columbia--(Newsfile Corp. - April 3, 2024) - Solarvest BioEnergy Inc. (TSXV: SVS) (“Solarvest” or the “Company”) is pleased to announce that it intends to hold its annual general meeting of shareholders (the “Meeting”) on May 10, 2024 in Vancouver, British Columbia.
April 3, 2024
·
2 min read
Press Releases
Sable Therapeutics Announces Exclusive Worldwide Licensing Agreement with Columbia University to Develop Novel Polycation Nanomedicines for the Treatment of Obesity
August 12, 2024
·
2 min read
Biotech Beach
Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society
Artelo Biosciences, Inc. today announced that Professor Saoirse O’Sullivan will be presenting new preclinical data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society.
June 4, 2024
·
4 min read
Izotropic Corporation Announces Closing of First Tranche of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic” or the “Company”) - Further to the Company’s news release of June 6, 2024, the Company is pleased to announce that...
June 14, 2024
·
3 min read
1 of 63,289
Next
